Navigation Links
Agrivida Announces Dan Meagher as Chief Executive Officer
Date:11/18/2013

MEDFORD, Mass., Nov. 18, 2013 /PRNewswire/ -- Agrivida, Inc., a biotechnology company developing technologies for animal nutrition, cellulosic sugars from biomass, and regulated enzymes, announced today the appointment of Dan Meagher as Chief Executive Officer. Mr. Meagher joins Agrivida from Novus International, where he was President of Global Animal Nutrition Solutions and responsible for global sales, marketing, animal R&D, business development, customer service, logistics & distribution and local manufacturing blend facilities.  Prior to Novus, Dan was President of the Egg Products Further Processing Business Unit at MOARK, LLC, a producer and marketer of shell eggs and egg products, COO & Executive Vice President at MBA Poultry LLC, and Vice President at Purina Mills. "I'm extremely excited to be joining Agrivida, whose technology represents a paradigm shift in delivering performance to the animal nutrition industry at the lowest cost possible," stated Mr. Meagher.

Dan takes over at Agrivida as Mark Wong is named to Chairman of Agrivida's Board of Directors.  "We are extremely fortunate to have Dan Meagher joining Agrivida to lead our team into this next phase of development," said Mr. Wong. "Dan's experience in the animal nutrition area will be critical to driving the commercialization of Agrivida's technology in several areas." Mr. Wong assumes the chairman position following five years of service as Agrivida's CEO. During his tenure, Mr. Wong led the company through several successful rounds of financing and established strategic relationships with corn seed and biofuels companies.

Agrivida's new leadership team represents a broadening of the company's expertise, reflecting its growing pipeline of biotechnology products for the animal nutrition, biofuels, and industrial enzyme markets. 

About Agrivida, Inc.

Agrivida is developing and commercializing high-performance products that incorporate novel, regulated proteins precisely engineered for specific applications in a variety of markets, including animal feed and nutrition, bio-based fuels and chemicals, and industrial enzymes. Agrivida is transforming the economics of industrial and agricultural production through our pioneering use of regulated enzymes to develop higher-efficiency, lower-cost biomass feedstocks and intermediate inputs.


'/>"/>
SOURCE Agrivida, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. POET And Agrivida Sign Technology Collaboration Joint Development Agreement
2. QIAGEN Announces Third Co-Development Program for Companion Diagnostics Paired With Lillys Investigational Cancer Compounds
3. Sangamo BioSciences Announces Presentation Of Clinical Data From Alzheimers Disease Program
4. Vet-Stem, Inc. Proudly Announces Distribution Agreement with Animal Health International, Inc. for Regenerative Cell Therapies
5. Ceres Announces Webcast of Fiscal Year 2013 Financial Results
6. Anterios, Inc., Announces Results of Consumer Survey Revealing Widespread Problem of Excessive Sweating and Desire for New Topical Botulinum Toxin Treatment
7. Cord Blood America Announces 2013 Third Quarter Financial Results
8. IPISC announces IP insurance for the Biotechnology/Pharma Industry
9. Z Trim Holdings, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
10. RXi Pharmaceuticals Announces the Start of Their First Phase 2 Study with RXI-109 for Treatment of Hypertrophic Scars in Conjunction with Scar Revision Surgery
11. LayerBio, Inc. Announces Launch; Signs Option for Technology from MIT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... MILFORD, Mass. , March 23, 2017 ... leading partner to global in vitro diagnostics ... launch of the industry,s first multiplexed ... inherited disease testing by next-generation sequencing ... materials were developed with input from industry ...
(Date:3/23/2017)... -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical ... reported financial results for the quarter and year ... update on the company,s clinical development efforts and ... pleased to report that last year was a ... Krammer. "We achieved key clinical milestones and attracted ...
(Date:3/23/2017)... -- Kineta, Inc., a biotechnology company focused on ... today announced the discovery and characterization of several ... interferon response factor 3 (IRF3) via RIG-I like ... in a murine colon carcinoma mouse model.  Furthermore, ... regression to initial drug treatment were resistant to ...
(Date:3/23/2017)... , March 23, 2017 According to ... products and derivatives market is fragmented due to the presence of a ... as Proliant, Thermo Fisher , and Sigma-Aldrich, compete with each ... three companies, collectively, held more than 76% of this market in ... As of ...
Breaking Biology Technology:
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017  IBM ... Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, Home ... that will apply the power of IBM cognitive computing ... health centers. By analyzing data streaming from sensors in ... physical and environmental conditions, and obtain deeper learnings into ...
(Date:2/14/2017)...  Wake Forest Baptist Medical Center today announced Julie Ann ... officer (CEO). Freischlag joins the medical center on May ... M.D., who last year announced that he would transition ... leading it since 2008.   As CEO, ... Baptist,s academic health system, which includes Wake Forest School ...
(Date:2/10/2017)... DUBLIN , Feb 10, 2017 ... PharmaBiotech,s new report "Personalized Medicine - Scientific and Commercial ... ... in personalized medicine. Diagnosis is integrated with therapy for selection ... emphasis on early detection and prevention of disease in modern ...
Breaking Biology News(10 mins):